Transfection of hPSC-Cardiomyocytes Using Viafect™ Transfection Reagent
{{output}}
Twenty years since their first derivation, human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) have shown promise in disease modelling research, while their potential for cardiac repair is being investigated. However, low transfection efficiency is a... ...